Survival associated miRNA signature in patients with head and neck carcinomas

Head and neck carcinoma (HNSC) is often diagnosed at advanced stage, incurring poor patient outcome. Despite of advances in chemoradiation and surgery approaches, limited improvements in survival rates of HNSC have been observed over the last decade. Accumulating evidences have demonstrated the impo...

Full description

Bibliographic Details
Main Authors: Srinivasulu Yerukala Sathipati, Shinn-Ying Ho
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023044262
_version_ 1797802778408517632
author Srinivasulu Yerukala Sathipati
Shinn-Ying Ho
author_facet Srinivasulu Yerukala Sathipati
Shinn-Ying Ho
author_sort Srinivasulu Yerukala Sathipati
collection DOAJ
description Head and neck carcinoma (HNSC) is often diagnosed at advanced stage, incurring poor patient outcome. Despite of advances in chemoradiation and surgery approaches, limited improvements in survival rates of HNSC have been observed over the last decade. Accumulating evidences have demonstrated the importance of microRNAs (miRNAs) in carcinogenesis. In this context, we sought to identify a miRNA signature associated with the survival time in patients with HNSC. This study proposed a survival estimation method called HNSC-Sig that identified a miRNA signature consists of 25 miRNAs associated with the survival in 133 patients with HNSC. HNSC-Sig achieved 10-fold cross validation a mean correlation coefficient and a mean absolute error of 0.85 ± 0.01 and 0.46 ± 0.02 years, respectively, between actual and estimated survival times. The survival analysis revealed that five miRNAs, hsa-miR-3605-3p, hsa-miR-629-3p, hsa-miR-3127-5p, hsa-miR-497-5p, and hsa-miR-374a-5p, were significantly associated with prognosis in patients with HNSC. Comparing the relative expression difference of top 10 prioritized miRNAs, eight miRNAs, hsa-miR-629-3p, hsa-miR-3127-5p, hsa-miR-221-3p, hsa-miR-501-5p, hsa-miR-491-5p, hsa-miR-149-3p, hsa-miR-3934-5p, and hsa-miR-3170, were significantly expressed between cancer and normal groups. In addition, biological relevance, disease association, and target interactions of the miRNA signature were discussed. Our results suggest that identified miRNA signature have potential to serve as biomarker for diagnosis and clinical practice in HNSC.
first_indexed 2024-03-13T05:10:48Z
format Article
id doaj.art-4db6b3cb9ff241a9a213d825a20bd313
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-13T05:10:48Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-4db6b3cb9ff241a9a213d825a20bd3132023-06-16T05:10:24ZengElsevierHeliyon2405-84402023-06-0196e17218Survival associated miRNA signature in patients with head and neck carcinomasSrinivasulu Yerukala Sathipati0Shinn-Ying Ho1Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 54449, USA; Corresponding author.Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Corresponding author. Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.Head and neck carcinoma (HNSC) is often diagnosed at advanced stage, incurring poor patient outcome. Despite of advances in chemoradiation and surgery approaches, limited improvements in survival rates of HNSC have been observed over the last decade. Accumulating evidences have demonstrated the importance of microRNAs (miRNAs) in carcinogenesis. In this context, we sought to identify a miRNA signature associated with the survival time in patients with HNSC. This study proposed a survival estimation method called HNSC-Sig that identified a miRNA signature consists of 25 miRNAs associated with the survival in 133 patients with HNSC. HNSC-Sig achieved 10-fold cross validation a mean correlation coefficient and a mean absolute error of 0.85 ± 0.01 and 0.46 ± 0.02 years, respectively, between actual and estimated survival times. The survival analysis revealed that five miRNAs, hsa-miR-3605-3p, hsa-miR-629-3p, hsa-miR-3127-5p, hsa-miR-497-5p, and hsa-miR-374a-5p, were significantly associated with prognosis in patients with HNSC. Comparing the relative expression difference of top 10 prioritized miRNAs, eight miRNAs, hsa-miR-629-3p, hsa-miR-3127-5p, hsa-miR-221-3p, hsa-miR-501-5p, hsa-miR-491-5p, hsa-miR-149-3p, hsa-miR-3934-5p, and hsa-miR-3170, were significantly expressed between cancer and normal groups. In addition, biological relevance, disease association, and target interactions of the miRNA signature were discussed. Our results suggest that identified miRNA signature have potential to serve as biomarker for diagnosis and clinical practice in HNSC.http://www.sciencedirect.com/science/article/pii/S2405844023044262Machine learningmiRNA signatureCancer survivalHead and neck cancer
spellingShingle Srinivasulu Yerukala Sathipati
Shinn-Ying Ho
Survival associated miRNA signature in patients with head and neck carcinomas
Heliyon
Machine learning
miRNA signature
Cancer survival
Head and neck cancer
title Survival associated miRNA signature in patients with head and neck carcinomas
title_full Survival associated miRNA signature in patients with head and neck carcinomas
title_fullStr Survival associated miRNA signature in patients with head and neck carcinomas
title_full_unstemmed Survival associated miRNA signature in patients with head and neck carcinomas
title_short Survival associated miRNA signature in patients with head and neck carcinomas
title_sort survival associated mirna signature in patients with head and neck carcinomas
topic Machine learning
miRNA signature
Cancer survival
Head and neck cancer
url http://www.sciencedirect.com/science/article/pii/S2405844023044262
work_keys_str_mv AT srinivasuluyerukalasathipati survivalassociatedmirnasignatureinpatientswithheadandneckcarcinomas
AT shinnyingho survivalassociatedmirnasignatureinpatientswithheadandneckcarcinomas